SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA's stellar earnings and robust AI-driven guidance were surprisingly met with a sharp sell-off, prompting intense community discussion centered on potential institutional options manipulation and overvaluation fears within the broader AI sector, with many investors actively calling it a strategic dip-buying opportunity.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending following a significant miss on recent financial results and disappointing guidance, which has sparked widespread investor anger and concerns over management's credibility. Despite community backlash and accusations of a pump-and-dump, a notable segment of investors views the sharp stock decline as an overreaction, presenting a potential 'buy the dip' opportunity in the long-term battery storage sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is a focal point of market discussion following its strong revenue performance and optimistic long-term guidance, amplified by significant government contract wins and strategic acquisitions, generating intense debate among investors over its valuation, future profitability, and high short interest.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending following its mixed Q4 earnings report and the announcement of CEO Doug Ingram's upcoming retirement, fueling community debate around the stock's perceived undervaluation. Investors are actively discussing potential catalysts like upcoming pipeline data from its siRNA programs and renewed buyout speculation, amidst persistent claims of market manipulation.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending with high anticipation ahead of its earnings report, as its expanding agentic AI platform through new offerings like Sales Assist and a strategic India innovation hub fuels investor excitement, while a notable short interest adds to community speculation about its valuation and growing presence across diverse sectors.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as a significant earnings beat and robust revenue growth are met with investor frustration over the stock's stagnant price action, igniting community debate and speculation about a potential buyout or partnership amidst management's notable silence regarding its AUR200 pipeline.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is highly active ahead of its earnings report and recent management commentary at the CAGNY conference, with community sentiment sharply divided over CEO performance and widespread speculation regarding a potential Pepsi buyout, even as impressive sales growth from Celsius and Alani Nu continues to draw bullish long-term conviction.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending following its Q4 2025 earnings report, which surpassed revenue and EPS expectations. This has ignited a community debate, with bulls citing the company's strong free cash flow and deep undervaluation, while bears remain focused on long-term growth challenges and management's execution.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing a surge of interest after beating Q4 earnings with reported profitability and securing new Material Transfer Agreements, notably in oncology, fueling intense community discussions about a potential short squeeze as its convertible debt conversion price comes into play.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as strong Q4 results, fueled by scaling AI workloads and growing commitments, are being overshadowed by conservative forward guidance, leading to analyst target cuts and sparking community debate over its volatile price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Abercrombie &amp; Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection.</li><li>The company narrowed its earnings per share (EPS) outlook to a range of $10.30 and $10.40 from the previous range of $10.20 to $10.50.&nbsp;</li><li>Capital expenditures are estimated at around $245 million, up from $225 million previously.</li></ul>Abercrombie &amp; Fitch Co. (ANF) on Monday trimmed its outlook for annual net sales growth, a move that rattled investors and pushed the retailer’s shares sharply lower.&nbsp;The apparel retailer released its outlook for the fourth quarter (Q4) and the full fiscal year 2025.&nbsp;<h2 class="st-heading-2">Guidance Update And Market Reaction</h2>Abercrombie &amp; Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range. The company expects an operating margin of approximately 13% and an effective tax rate near 30%.The company narrowed its earnings per share (EPS) outlook to a range of $10.30 and $10.40 from the previous range of $10.20 to $10.50. The analysts' consensus estimate according to Fiscal AI data is $9.82.&nbsp;Retailers across the sector have faced shifting consumer spending patterns, uneven demand for discretionary goods, and heightened sensitivity to pricing as inflation and interest rates pressure household budgets.<a href="https://stocktwits.com/symbol/ANF">Abercrombie &amp; Fitch stock&nbsp;</a>tumbled by over 16% lower on Monday mid-morning. However, on Stocktwits, retail sentiment around the stock shifted to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_12_121129_png_f9241b1f1b.webp" alt="ANF’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Jan. 12, 2026 | Source: Stocktwits" width="929" height="97"><figcaption>ANF’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Jan. 12, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Capital Expenditure Jumps&nbsp;</h2>Capital expenditures are estimated at around $245 million, up from $225 million previously. Abercrombie &amp; Fitch also plans roughly 40 net store openings, along with 40 remodels and right-sizing efforts.&nbsp;For Q4, the retailer anticipates net sales growth of around 5%, with operating margins at roughly 14%.&nbsp;Earnings per diluted share are expected between $3.50 and $3.60 with a consensus estimate of $3.60, according to Fiscal AI data. Share repurchases for the quarter are projected at approximately $100 million.&nbsp;ANF stock has declined by over 23% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-to-use-google-s-gemini-ai-for-siri-overhaul-report/cmUa2VCR4E0">Apple To Use Google’s Gemini AI For Siri Overhaul: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holds a smartphone displaying the logo of Abercrombie & Fitch Co. 

Why Did Abercrombie & Fitch Stock Plunge Over 16% Today? 

Abercrombie & Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range.

Equity

Abercrombie & Fitch anticipates at least 6% growth in net sales for 2025, dialing back from its earlier projection that called for growth in the 6% to 7% range.


PAMC
Pacer Funds Trust - Pacer Lunt MidCap Multi-Factor Alternator ETF

Feed

News

Sentiment

Fundamentals

Info

Latest PAMC News

PAMCPacer Funds Trust - Pacer Lunt MidCap Multi-Factor Alternator ETF